Warrior CBD: Convenience at its Finest
NEW YORK, NY / ACCESSWIRE / December 4, 2019 / CBD (or cannabidiol) seems to be everywhere lately. It has grown into popularity since it has been introduced in the market and CBD brands have been positioning and constantly differentiating themselves from the rest. There is a fast growing market that is interested to know and understand what works best for them. Aside from that, they are looking to trust a brand that is transparent, convenient to order and one that offers money-back guarantees – a sure value for their money. Like, Warrior CBD.
Warrior CBD is a startup CBD (or cannabidiol) e-commerce company that was recently launched in January of this year. Within the short span of six months, it has quickly grown its customer base to over 29 US States and has steadily grown since.
Warrior CBD products are produced with a proprietary extraction method from hemp plants grown in Evergreen, Colorado to produce ultra-premium quality CBD. With many CBD products on the market, consumers do not always know where their products come from, what’s inside it, if the CBD has THC or not, among many other questions. With their product, you know where it’s made and what the ingredients are.
Warrior CBD oil is full spectrum. This “full spectrum” oil, unlike a lot of the isolate oils sold on the market, contains all of the cannabinoids and terpenes from the plant instead of just an “isolate”. According to research, consuming all of the naturally occurring cannabinoids and terpenes can help produce the “entourage” effect that yields maximum health benefits.
One of Warrior CBD’s advantages as an e-commerce brand is they are able to ship orders to any state in the USA, with guaranteed three-day US shipping on all orders. This is compared to retail CBD stores that can only serve local markets. Wherever you are in the country, Warrior CBD will deliver.
Aside from that, Warrior CBD values excellent customer service. They take pride in being a transparent company making sure every customer knows what inside their products. They also have a thirty-day money-back guarantee which makes them stand out from the rest. Most CBD brands don’t offer money-back guarantees to their customers. For Warrior CBD, it’s all about their customers loving their brand and making a difference in their lives.
With a growing team of 15 brand ambassadors, Warrior CBD is a top recommended product by some of the top jiu jitsu practitioners in the DFW area and in the country.
SOURCE: Warrior CBD
Israel expects $220 million in non-defence trade with Bahrain in 2021
Royal Bank, National Bank of Canada profit beat estimates on lower than expected provisions
North Korea-linked hackers targeted J&J, Novavax in hunt for COVID research
WRAPUP 1-Royal Bank, National Bank of Canada profit beat estimates on lower than expected provisions
UK approval of COVID-19 vaccine won’t affect Germany’s doses – ministry
How to Avoid Paying Taxes on Inherited Property
Inheriting a home or other property can increase the value of your estate but it can also result in tax consequences. If the property you inherit has appreciated in value since the original owner purchased it, you could be on … Continue reading ->The post How to Avoid Paying Taxes on Inherited Property appeared first on SmartAsset Blog.
3 Airline Stocks Ready for Takeoff
Airlines stocks have shown signs of a turnaround over the last month. Here are three to put on the radar.
Tesla CEO says he is open to friendly deal with rival carmaker
Tesla Chief Executive Elon Musk on Tuesday said he was open to discussing a merger of his start-up electric carmaker with a rival. Speaking at an Axel Springer event in Berlin, Musk was asked whether he would consider buying a rival carmaker given that Tesla’s market value of more than $500 billion would make it easy to launch a takeover bid.
Workhorse Shares Fall On Delayed USPS Mail Truck Decision
Shares of Workhorse Group (NASDAQ: WKHS) are down in after-hours trading Tuesday on news of a delay for the long-awaited U.S. Postal Service contract.What Happened: The USPS is delaying its contract decision on the USPS replacement vehicles, according to Trucks.com.The USPS told Trucks it expects to make a decision in the second fiscal quarter of 2021. This decision has been delayed multiple times already and now puts pressure on Workhorse, one of three finalists for the contact.”Amid continuing Covid-19 concerns, and in order to provide for capital investment activities and required approvals, the program schedule has been revised and a decision is now planned for quarter 2 of fiscal year 2021,” the USPS said in a statement.Related Link: Workhorse CFO Steve Schrader On The Status Of The USPS ContractWhy It’s Important: The USPS is set to award a $6 billion contract for 180,000 delivery vehicles. Workhorse Group is one of the finalists along with Turkey-based Krsan and Oshkosh Corporation (NYSE: OSK).Shares of Workhorse are up over 700% in 2020 and investors could sell the delay news.WKHS Price Action: Shares of Workhorse fell 14% to $21.75 in after-hours trading.See more from Benzinga * Click here for options trades from Benzinga * Why Barstool, MGM Could Be Big Winners With Michigan Online Sports Betting * Musk Wants Tesla Employees To Pinch Pennies For Profitability(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
A ‘severe’ drop is imminent, this stock market is signaling, says contrarian strategist
Investors are crowding into the stock market right now, and they aren’t seeing the big signals that indicate they are about to get caught up in a rough period of selling, says our call of the day from contrarian investor Steven Jon Kaplan.
Merck Sells Equity Stake in Moderna Following Record Gains For Coronavirus Vaccine Maker
Merck & Co, an early investor in coronavirus vaccine maker Moderna, has sold its equity stake following a record year of gains for the Cambridge, Massachusetts-based biotech.
Li Auto’s stock erases gains after delivery data, as other China-based EV makers keep falling
Shares of Li Auto Inc. reversed course to trade slightly lower Wednesday, even after the Beijing-based company reported a monthly record of deliveries in November, as the stocks of other China-based electric vehicle makers continued to pull back.
Dow Jones Futures Fall Amid Pfizer Coronavirus Vaccine Approval; Apple Hits New Buy Point
Dow Jones futures were in focus early Wednesday after Apple hit a new buy point. AMD, PayPal and Facebook are in or near buy zones.
2 Big Dividend Stocks Yielding 10%; Raymond James Says ‘Buy’
Dividend stocks are the Swiss army knives of the stock market.When dividend stocks go up, you make money. When they don’t go up — you still make money (from the dividend). Heck, even when a dividend stock goes down in price, it’s not all bad news, because the dividend yield (the absolute dividend amount, divided by the stock price) gets richer the more the stock falls in price.Knowing all this, wouldn’t you like to find great dividend stocks? Of course you would. Raymond James analysts have chimed in – and they are recommending two high-yield dividend stocks for investors looking to find protection for their portfolio. These are stocks with a specific set of clear attributes: a dividend yield of 10% and Strong Buy ratings.Kimbell Royalty Partners (KRP)We’ll start with Kimbell Royalty Partners, a land investment company operating in some of the US’ major oil and gas producing regions: the Bakken of North Dakota, Pennsylvania’s Appalachian region, the Colorado Rockies, and several formations in Texas. Kimbell owns mineral rights in more than 13 million acres across these regions, and collects royalties from over 95,000 active wells. Over 40,000 of those wells are in the Permian Basin of Texas, the famous oil formation that has, in the past decade, helped turn the US from a net importer of hydrocarbons to a net exporter.The coronavirus crisis hit Kimbell directly in the pocketbook, knocking down share prices and earnings as economic restrictions, social lockdowns, and the economic downturn all struck at production and demand. The situation has only begun to revive, with the Q3 revenues growing 44% sequentially to reach $24.3 million.Kimbell has long been a reliable dividend payer, with a twist. Where most dividend stocks keep their payouts stable, typically making just adjustment in a year, Kimbell has a history of reevaluating its dividend payment every quarter. The result is a dividend that is rarely predictable – but is always affordable for the company. The last declaration, for the third quarter, was 19 cents per common share, or up 46% from the previous quarter. At that rate, the dividend yields
10%,Covering the stock for Raymond James, analyst John Freeman noted, “Despite a strong quarterly performance and a nearly 50% distribution raise in 3Q, the market continues to under appreciate the unique value proposition of Kimbell’s assets, in our view. Kimbell has a best-in-class 13% base decline, exposure to every major basin and commodity, as well as a very manageable leverage profile…”Regarding the possible anti-hydrocarbon stance of a Biden Administration, Freeman sees little reason for worry, saying, “Investors concerned about a potential Biden presidency (which appears increasingly likely) have little to fear in KRP. The company has less than
2% of acreage on federal lands, meaning a frac ban on those properties would not have a material impact on KRP’s business and might actually help them if it improved the overall supply impact.”In line with these comments, Freeman rates KRP a Strong Buy, and his $9 price target implies it has room for 25% growth going forward. (To watch Freeman’s track record, click here)Wall Street appears to agree with Freeman, and the analyst consensus view is also a Strong Buy, based on 5 unanimous positive reviews. This stock is priced at $7.21, and its $11 average target is even more bullish than Freemans, suggesting a one-year upside of
52%. (See KRP stock analysis on TipRanks)NexPoint Real Estate Finance (NREF)NexPoint inhabits the real estate trust niche, investing in mortgage loans on rental units, both single- and multi-family occupancy, along with self-storage units and office spaces. The company operates in the US, across major metropolitan hubs.NexPoint held its IPO in February this year, just before the coronavirus pandemic inspired an economic crisis. The offering saw 5 million shares sell, and brought in some $95 million in capital. Since then, the shares are down 13%. Earnings, however, have posted gains in each full quarter that the company has reported as a public entity, coming in at 37 cents per share in Q2 and 52 cents in Q3. The Q3 number was 30% above the forecast.The dividend here is also solid. NexPoint started out with a 22-cent per share payment in Q1, and raised it in Q2 to its current level of 40 cents per common share. This annualizes to $1.60, making the yield an impressive
10%.Stephan Laws, 5-star analyst with Raymond James, is impressed with what he sees here. Laws writes of NexPoint, “Recent investments should drive significant core earnings growth, which is reflected in the increased 4Q guidance range of $0.49-0.53 per share (up from $0.46-0.50 per share). The guidance incorporates the full quarter impact of the new 3Q investments as well as new mezz investments made in October. We are increasing our 4Q and 2021 estimates, and we have increased confidence in our forecast for a 1Q21 dividend increase, which we now forecast at $0.45 per share…”Following these sentiments, Laws puts a Strong Buy rating on NREF. His $18 price target suggest the stock has a 9% upside potential for the year ahead. (To watch Laws’ track record, click here)With 2 recent Buy reviews, the analyst consensus on NREF shares is a Moderate Buy. The stock’s $18 average price target matches Laws’, implying 9% growth. (See NREF stock analysis on TipRanks)To find good ideas for dividend stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights.Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.
Dow Jones Loses Ground Late As McConnell Shoots Down Stimulus Plan; Tesla Gains Again
The Dow Jones gave up gains late after Senate Majority Leader Mitch McConnell shot down a proposed coronavirus stimulus plan.
These 2 “Strong Buy” Penny Stocks Could Go Boom, Says Roth Capital
What kind of stocks stir up controversy like no other? Penny stocks. These tickers trading for less than $5 per share have earned a reputation as some of the most divisive names on Wall Street, with these plays either met with open arms or given the cold shoulder.It’s understandable why some investors are wary. Those opposed are quick to point out that there could be a very real reason these stocks are changing hands for pocket change, with the low share prices often masking obstacles like weak fundamentals or troubling headwinds. That said, others are drawn in by the sheer growth potential of penny stocks. The fact is that even minor share price appreciation can mean huge percentage gains, and thus, serious returns. What’s more, your money goes further with these bargain names.No matter which side you take, one thing is certain, due diligence is necessary before making any investment decisions. That’s where the experts come in, namely the analysts at Roth Capital. These pros bring experience and in-depth knowledge to the table.With this in mind, our focus turned to two penny stocks that have received a thumbs up from Roth Capital analysts. Running the tickers through TipRanks’ database, both have been cheered by the rest of the Street as well, as they boast a “Strong Buy” analyst consensus. Not to mention substantial upside potential is on the table.Cellectar Biosciences (CLRB)Leveraging its patented phospholipid drug conjugates (PDCs) delivery platform, Cellectar Biosciences develops cutting-edge treatments for cancer. Based on the potential of its drug candidate, CLR 131, and its $1.24 share price, Roth Capital thinks that now is the time to get in on the action.Representing the firm, analyst Jonathan Aschoff tells clients that he is optimistic about CLR 131, which is a small-molecule, targeted PDC designed to deliver cytotoxic radiation directly and selectively to cancer cells, in the lymphoplasmacytic lymphoma (LPL)/Waldenstrom’s macroglobulinemia (WM) indications. According to Aschoff, following its Type B guidance meeting with the FDA, “CLRB is prepared to initiate its first pivotal CLR 131 trial in LPL/WM after achieving a 100% ORR and 75% major response rate in four patients.” He points out that although CLRB just reported promising results in multiple myeloma (MM) (40% ORR in triple class refractory (TCR) patients at total body doses of at least 60mCi), LPL/WM was selected for the initial pivotal trial based on the very strong initial results and the lower competition for patients.“We view this as a prudent decision because NCCN compedia listing in MM is a mere peer-reviewed publication away, if first approved in LPL/WM. We also note that CLRB has steadily improved its dosing of CLR 131, essentially fractionating the doses so that higher total body doses are well tolerated,” Aschoff further explained. Adding to the good news, the therapy generated activity in preliminary Phase 1 unresectable brain tumors. Aschoff added, “Disease control was shown in two heavily pretreated patients with ependymomas, showing the drug’s ability to cross the blood brain barrier, and all doses through 60 mCi/m2 have exhibited a favorable safety profile.”To this end, Aschoff rates CLRB a Buy along with a $10 price target. Investors could be pocketing a gain of 713%, should this target be met in the twelve months ahead. (To watch Aschoff’s track record, click here)Are other analysts in agreement? They are. 5 Buys and no Holds or Sells have been issued in the last three months. So, the message is clear: CLRB is a Strong Buy. Given the $5.48 average price target, shares could soar 345% from current levels. (See CLRB stock analysis on TipRanks)Applied Genetic Technologies (AGTC)With vast gene therapy experience, Applied Genetic Technologies designs and constructs all critical gene therapy elements and brings them together to develop successful treatments for patients. Currently going for $4.50 apiece, Roth Capital believes this stock’s long-term growth narrative is strong.Firm analyst Zegbeh Jallah points out that recently released data for its XLRP gene therapy program, which is expected to enter pivotal studies in Q1 2021, reaffirmed his bullish thesis. “Despite the market not fully appreciating the data given how the stock traded, we continue to believe that the results suggest that AGTC could have a best-in-class therapy, which is supportive of the planned pivotal efforts,” he explained.Providing an update on the results of the Phase 1/2 XLRP study, using the FDA’s criteria, AGTC evaluated responses at 12 months in the lower dose groups (2 and 4), and 6 months in the higher dose groups (5 and 6). According to Jallah, “initial responses were observed in dose Groups 2, 3, 4, 5 and 6, with impressive response durability even at 12 months.”On top of this, at 6 months, the dose used in Group 5 resulted in a 43% response rate or a 57% response rate if excluding a patient not meeting the enrollment criteria. In Group 6, a response rate of 50% was observed, or 100% excluding patients not meeting the enrollment criteria.Jallah added, “All measurements were obtained in the 36 perimetry grid, which we believe should make it easier to preselect loci likely to respond. Although BCVA is not the primary endpoint, BCVA improvements, which can capture changes in the central region, were maintained at 12 months.”Even though some investors have expressed concern about Meira’s competing therapy, Jallah believes AGTC’s technology could have a leg up. “Overall, we believe that the data from both companies is strongly indicative of the efficacy potential of gene therapy for inherited retinal disease, and although differences in the study design makes direct comparisons difficult, we believe that AGTC could have a competitive advantage heading into pivotal studies,” he commented.In line with his optimistic approach, Jallah reiterated a Buy rating and $30 price target, indicating 568% upside potential. (To watch Jallah’s track record, click here)All in all, other analysts echo Jallah’s sentiment. 5 Buys and zero Holds or Sells add up to a Strong Buy consensus rating. The average price target of $18.25 is less aggressive than Jallah’s but still leaves room for upside potential of 306%. (See AGTC stock analysis on TipRanks)To find good ideas for penny stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights.Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.
Nio, Xpeng EV Sales Jump As Wall Street Sees Leaders Emerge From The Pack
Nio and Xpeng reported a jump in November sales, and Goldman Sachs hiking its price targets on Nio and Li Auto.
5 of the Most Shorted Stocks of December
Instead of betting on stock prices to rise, short sellers take the opposite side of the trade and profit when stock prices fall. Rising short interest can be a red flag for investors, but it can also set up a phenomenon known as a short squeeze. Short squeezes are large, short-term spikes in a stock that can occur when short sellers exit their positions all at once by buying shares of stock.
EV Stocks With Long-Term Potential
Despite 2020 being an unprecedented year due to the pandemic, it will also be remembered as the year for the EV revolution. While EV companies, led by Tesla Inc (NASDAQ: TSLA), have been around for a while, 2020 was the year the markets officially became infatuated with its potential to disrupt the traditional automakers. Tesla shares are up nearly 600% for the year, and a number of up-and-comers have shown strong performances and even greater promises.Although this performance might not be sustainable over the long-run, the potential of electrification is real. Traditional automakers such as the German giant Volkswagen A G (OTC: VWAGY) know it and are investing heavily to catch the electric wave. But despite such ‘safe-bets’, there are also many other up-and-comers such as Li Auto Inc. (NASDAQ: LI), NIO Inc (NYSE: NIO), and Xpeng Inc (NYSE: XPEV) who show great potential.The SUV SpecialistLi Auto went public only in late July, but the shares of the Chinese maker of electric SUVs are up 142% in just four months since then. Its market cap at $34 billion is in line with that of Ford Motor Company (NYSE: F) despite having one-tenth of the revenue.Li might be selling only one vehicle at the moment, family-sized SUV named the Li One, but it has four additional SUVs planned. More importantly, the Li One also comes with an onboard gasoline generator that supplements the battery and acts as a range extender, removing the range anxiety for its customers as the charging infrastructure is yet to catch up. Li Auto expects to sell about 30,000 vehicles this year, but Goldman Sachs Group Inc (NYSE: GS) analyst Fei Fang finds Li has what it takes to manufacture up to about 500,000 annually by 2025 and without much-added construction cost.But even if there could be some near-term turbulence, Li has positioned itself well in an attractive niche in the Chinese market with a product that is selling well.A Well-Positioned Chinese EV Maker China is the world’s largest new-vehicle market with the government pushing the adoption of electric vehicles. According to Bank of America Corp (NYSE: BAC), NIO and Tesla together have about 90% of the market for premium electric vehicles in China. Nio is the homegrown favorite and that counts for something. Moreover, after a near-bankruptcy experience early in 2020, it’s now the cash and resources to increase production. It’s a safe bet to expect that big sales growth is coming given its production plan.Next-Generation Autonomous EVsFrom barely $1 million in sales in 2018, XPeng has booked more than half a billion dollars in sales over the last 12 months. By 2022, data from S&P Global Market Intelligence reports that analysts project XPeng will tip the scales at a mind-boggling $4.1 billion. If this ends up being the case, it means XPeng will go from $1 million to more than $4 billion in sales in less than four years.Last week, it unveiled a “next-generation autonomous driving architecture” with which its EVs will become increasingly autonomous. This self-driving feature will be accomplished through cameras, radar, ultrasonic sensors, and lidar. Lidar is a laser for imaging, detection, and ranging. According to its press release will be the first car company in the world to incorporate lidar into a production-ready car, beginning with vehicles in its 2021 lineup.Such ground-breaking technological leadership should help XPeng secure a strong position in the Chinese automotive market, where EV sales are expected to grow 43% annually over the next five years.Volkswagen’s New EVThe German giant aims to produce 1.5 million electric cars by 2025. In November, it increased its planned investment in electrification to $86 billion over the next half of a decade. The carmaker increased the proportion of hybrid and electric vehicles in its European car sales from a previous target of 40% to 60% by 2030.To boost its sales in the EV era, Volkswagen is bringing forward the development of a small electric car for the mass market in anticipation of tougher EU climate regulations, according to plans seen by Reuters. A “Small BEV (Battery Electric Vehicle)” will be available in the range between $24,000 and $30,000. This would make it cheaper than Volkswagen’s ID.3 electric car that was launched for sale in September. Besides revealing it will be around the size of a Polo, no information was provided regarding its look, launch date or the place where it will be built.With Great Risk Comes Great Reward There’s a lot of risk involved in EV stocks, but also a lot of potential as a whole new era is ahead. The above four companies are well-positioned to benefit from this super trend.This article is not a press release and is contributed by a verified independent journalist for IAMNewswire. It should not be construed as investment advice at any time please read the full disclosure. IAM Newswire does not hold any position in the mentioned companies. Press Releases – If you are looking for full Press release distribution contact: [email protected] Contributors – IAM Newswire accepts pitches. If you’re interested in becoming an IAM journalist contact: [email protected] post EV Stocks With Long-Term Potential appeared first on IAM Newswire.Photo by Eduardo Arcos on UnsplashSee more from Benzinga * Click here for options trades from Benzinga * Autodesk Is Firing On All Cylinders, But Its Mastermind Is Joining Cisco * The COVID-19 Vaccine Front Runner Updates(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
UBS Downgrades Occidental Petroleum, Recommends 3 Other Oil Stocks
Occidental Petroleum Corporation (NYSE: OXY) shares are up 68% in the last month, and the stock’s big run triggered a Wall Street downgrade on Tuesday.The Analyst: UBS analyst Lloyd Byrne downgraded Occidental from Neutral to Sell and raised the price target from $10 to $12.Related Link: Why BofA Securities Is Overweight Energy Stocks In 2021The Thesis: In the downgrade note, Byrne said the company’s debt concerns have been mitigated, but its recent rally has carried the stock too far too fast based on its valuation.”We believe OXY is now discounting $53-55/bbl WTI going forward (significantly above the forward curve), and we see more compelling better risk/reward elsewhere in the group,” the analyst said. Occidental investors should consider rotating to oil stocks with more compelling valuations, such as Canadian Natural Resources Ltd (NYSE: CNQ), ConocoPhillips (NASDAQ: COP) and EOG Resources Inc (NYSE: EOG), he said. Despite the recent bounce in oil prices, Byrne said he does not anticipate Occidental being under 3x leverage until 2025. Occidental’s capital spending cuts have reduced the production outlook in 2021 and beyond, which UBS projects will weigh on long-term EBITDA and free cash flow.In the meantime, Byrne said he expects Occidental’s Colombia divestiture to close as expected and said investors should expect additional asset sales in the near-term.These deals could serve as bullish catalysts for the stock depending on their valuation, the analyst said. For now, however, he said any incremental FCF that Occidental generates will go to debt reduction.Benzinga’s Take: It’s not often an analyst will downgrade a stock to Sell and simultaneously raise their price target by 20%. Yet Occidental has rallied from under $9 in late October to above $15 in just over a month’s time.Latest Ratings for OXY DateFirmActionFromTo Dec 2020UBSDowngradesNeutralSell Nov 2020SusquehannaUpgradesNeutralPositive Nov 2020Morgan StanleyMaintainsEqual-Weight View More Analyst Ratings for OXY View the Latest Analyst RatingsSee more from Benzinga * Click here for options trades from Benzinga * Bearish Ford Option Trader Bets .1M Stock Is Headed Lower Over The Next 2 Years * The Libra Cryptocurrency Rebrands As ‘Diem'(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Hewlett Packard Enterprise to Leave Silicon Valley for Texas
(Bloomberg) — Hewlett Packard Enterprise Co. will move its headquarters to Houston, a major shift for a founding Silicon Valley computer maker now seeking haven in a lower-cost region while making way for a new generation of nimbler mobile and consumer-web giants.The company said it was already building a “state-of-the-art” new campus in Houston, the fourth-largest U.S. city. HPE also reported quarterly revenue that topped analysts’ predictions, suggesting that businesses are upgrading their data-center hardware during the coronavirus pandemic.HPE was created in the 2015 split of one of the consummate Bay Area technology companies, Hewlett-Packard Co., which was founded in 1939 in a Palo Alto garage. The move to Texas comes amid a broader re-evaluation, motivated by pandemic-enforced work-from-anywhere arrangements, by individuals and companies opting to leave behind a region known for its high cost of living and difficult commute.Chief Executive Officer Antonio Neri has been working to turn around HPE, a maker of servers, storage hardware and networking gear, which had reported declining revenue in all but one quarter since separating from personal-computer maker HP Inc. Neri is reducing the company’s overhead costs, exiting unprofitable businesses and chasing the hybrid-cloud market, in which businesses store and process some of their information in corporate data centers and some with public cloud companies.Sales in the quarter ended Oct. 31 were little changed from a year ago at $7.2 billion. Analysts, on average, estimated $6.9 billion, according to data compiled by Bloomberg. Profit, excluding some items, was 37 cents a share in the fiscal fourth quarter, HPE said Tuesday in a statement. Analysts had projected 34 cents.The spread of Covid-19 and the economic slowdown it triggered had suppressed demand for networking and computer hardware and services. Now that companies have settled into remote work for many employees, they’re investing in gear to make that more efficient.“The global pandemic has forced businesses to rethink everything from remote work and collaboration to business continuity and data insight,” Neri said in the statement. “We saw a notable rebound in our overall revenue, with particular acceleration in key growth areas of our business.”Hewlett Packard Enterprises follows a handful of other companies exiting at least in part from the San Francisco Bay Area. Newly public data-mining provider Palantir Technologies Inc. moved to Denver from Palo Alto earlier this year, while besieged e-cigarette maker Juul Labs Inc. is relocating to Washington from San Francisco. Charles Schwab Corp. said last year its headquarters will shift from San Francisco to Westlake, Texas. Many individuals, encouraged by laissez-faire work-from-home rules and put off by the cost of living in California, are also on the move.As Hewlett Packard Enterprises and its predecessor company receded from prominence in recent years, newer companies — such as Alphabet Inc., Apple Inc. and Facebook Inc. — have taken their place in the Silicon Valley pantheon.Fiscal fourth-quarter sales increased 6% from the prior period. In the current quarter, HPE projected that profit, excluding some items, will be 40 cents to 44 cents. That compares with an average analyst prediction of 35 cents, according to data compiled by Bloomberg. The company said sales will decline from the preceding period at a percentage in the mid-single digits, in line with normal seasonal patterns. A decline of 5% would indicate sales of about $6.84 billion. That compares with an average analyst estimate of $6.63 billion.The company will keep its technology innovation hub in San Jose, at a relatively new building, CEO Neri said on a conference call with analysts. Administrative work will be centered at the new Texas headquarters. Consolidating more expensive facilities in California will lead to real estate cost savings, he said.No staff reductions are associated with the move, HPE said in the statement. The company has locations in several cities in Texas, including Austin and Plano, and has more than 2,600 workers in Houston, according to a statement from the office of Governor Greg Abbott.HPE shares were little changed in extended trading after closing at $11.20 in New York. They have declined 29% this year.(Adds other companies leaving the Bay Area starting in eighth paragraph)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.
The Real Reason Why Tesla Is Heading Towards A Trillion-Dollar Valuation
Electric vehicle companies are currently the stars of the stock market, but savvy investors are focused on a bigger and potentially more profitable pictureNEW YORK, NY / ACCESSWIRE / December 4, 2019 / CBD (or cannabidiol) seems to be everywhere lately. It has grown into popularity since it has been introduced in the market and CBD brands have been positioning and constantly differentiating themselves from the rest. Warrior CBD is a startup CBD (or cannabidiol) e-commerce company that was recently launched in January of this year. ]]>